Cargando…
Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
Infliximab belongs to the family of tumor necrosis factor (TNF) alpha inhibitors and since its development, it has revolutionized treatment for both rheumatological diseases and inflammatory bowel disease (IBD). In IBD specifically, it has shown to result in symptomatic, endoscopic, and histological...
Autores principales: | Nasir, Syed Alishan, Patel, Ronak, Wojkiewicz, Steven, Scatena, Robyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883057/ https://www.ncbi.nlm.nih.gov/pubmed/36721597 http://dx.doi.org/10.7759/cureus.33064 |
Ejemplares similares
-
Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn’s disease or ulcerative colitis
por: Gheorghe, Cristian, et al.
Publicado: (2019) -
Pylephlebitis With Splenic and Mesenteric Vein Thrombosis in a Patient With Diverticulitis
por: Nasir, Syed Alishan, et al.
Publicado: (2022) -
Cytomegalovirus Colitis in a Patient With Ulcerative Colitis on Vedolizumab Monotherapy
por: Meeralam, Yaser, et al.
Publicado: (2023) -
Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)
por: Seagrove, Anne C, et al.
Publicado: (2014) -
Microcarcinoid and Ulcerative Colitis: Case Report and Literature Review
por: Etienne, Denzil, et al.
Publicado: (2020)